Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
The pioneer human oral commensal bacterium Streptococcus mitis has unique biologic features that make it an attractive mucosal vaccine or therapeutic delivery vector. S. mitis is safe as a natural persistent colonizer of the mouth, throat and nasopharynx and the oral commensal bacterium is capable o...
Main Authors: | Emily Xie, Abhiroop Kotha, Tracy Biaco, Nikita Sedani, Jonathan Zou, Phillip Stashenko, Margaret J Duncan, Antonio Campos-Neto, Mark J Cayabyab |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4664415?pdf=render |
Similar Items
-
Correction: Oral Delivery of a Novel Recombinant Streptococcus mitis Vector Elicits Robust Vaccine Antigen-Specific Oral Mucosal and Systemic Antibody Responses and T Cell Tolerance.
by: Emily Xie, et al.
Published: (2016-01-01) -
StreptoBase: An oral Streptococcus mitis group genomic resource and analysis platform
by: Zheng, W., et al.
Published: (2016) -
<i>Streptococcus mitis</i> and <i>Prevotella melaninogenica</i> Influence Gene Expression Changes in Oral Mucosal Lesions in Periodontitis Patients
by: Uros Tomic, et al.
Published: (2023-09-01) -
The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae.
by: Stian André Engen, et al.
Published: (2014-01-01) -
Cyclic Di-adenosine Monophosphate Regulates Metabolism and Growth in the Oral Commensal <i>Streptococcus mitis</i>
by: Gro Herredsvela Rørvik, et al.
Published: (2020-08-01)